Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Neuroblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02786719
What this trial is testing

High-Risk Neuroblastoma Chemotherapy Without G-CSF

Who this might be right for
Neuroblastoma
Baylor College of Medicine 13
Not applicableWithdrawnNCT00378781
What this trial is testing

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Who this might be right for
Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Early research (Phase 1)Looking for participantsNCT06485947
What this trial is testing

Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

Who this might be right for
Neuroblastoma
Princess Maxima Center for Pediatric Oncology 38
Testing effectiveness (Phase 2)Study completedNCT00253435
What this trial is testing

N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 50
Testing effectiveness (Phase 2)Study completedNCT00186849
What this trial is testing

Therapy for Children With Advanced Stage High Risk Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 30
Not applicableStudy completedNCT01510600
What this trial is testing

Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Oncology Group 99
Early research (Phase 1)Study completedNCT01419834
What this trial is testing

Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 68
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Early research (Phase 1)Study completedNCT00644696
What this trial is testing

Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
University of Michigan Rogel Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT03786783
What this trial is testing

Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma

Who this might be right for
GanglioneuroblastomaHigh Risk Neuroblastoma
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00003191
What this trial is testing

Fenretinide in Treating Children With Solid Tumors

Who this might be right for
NeuroblastomaUnspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00048386
What this trial is testing

Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy

Who this might be right for
Neuroblastoma
Malcolm Brenner 13
Early research (Phase 1)Active Not RecruitingNCT07007117
What this trial is testing

PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed NeuroblastomaHigh-Risk Neuroblastoma
Stephan Grupp MD PhD 38
Very early researchUnknownNCT00790413
What this trial is testing

Haploidentical Stem Cell Transplantation in Neuroblastoma

Who this might be right for
Neuroblastoma
Lund University Hospital 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT01757626
What this trial is testing

Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 186
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00053118
What this trial is testing

Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+1 more
Roswell Park Cancer Institute 1
Early research (Phase 1)Study completedNCT00885326
What this trial is testing

N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 29
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Next Page